Credits: Canva
Zoonotic diseases can spread from animals, including the ones we consume or keep as pets, including cats. Why are we talking about cats today? It is because of the increasing numbers of bird flu in the United States, cats of all shapes and sizes have come down with bird flu.
Bird flu was seen in poultry, where chickens have been affected, and even cows too. Why is it a concern for cats? This is because barn cats drink raw milk. In recent days, 20 wild cats at a Washington State animal sanctuary that ate infected birds and other reports of indoor cats dying from eating contaminated food have come out.
One of the leading causes is that unlike dogs, cats hunt for smaller prey, which includes birds and mice, carriers of bird flu. Dr Michael Bailey, the president-elect of the American Veterinary Medical Association (AVMA), in a guidance released for cat owners noted that by their very nature, cats have more "opportunity" to ger infected with bird flu.
“We don't know if the cats are more susceptible than anybody else,” he said. “It's just the fact they're exposed to higher viral burdens because of where they go.”
Reports say that domestic cats have been bird flu virus carrier since 2004. Kristen Coleman, an assistant professor at the University of Maryland School of Public Health told a media outlet that before, about half of cats died, and now with the spreading of the bird flu even in cows, about 90% of them seem to be dying. Coleman has also been tracking the deaths. She has also shared 4 main tips to protect pets from bird flu which includes:
As per AVMA, pet owners must look out for signs like:
Bird flu infection can also progress with neurologic signs, which includes:
Cats may also suffer from:
Sick animals may also be able to transmit influenza virus to humans through their saliva, excretion and other bodily fluids. People can also get infected by breathing in the virus or by touching something that has virus on it and then touching their eyes, mouth, or nose.
If you think your cat might have bird flu—or any other infectious disease—try to limit their contact with other pets and people in your household, especially those with weakened immune systems, until you get advice from a veterinarian, as recommended by the AVMA. While the chances of cats transmitting H5N1 to humans are extremely low, they aren’t zero.
According to CDC guidance, keep an eye on yourself and your family for flu-like symptoms and reach out to a healthcare provider if needed. Be sure to wash your hands thoroughly after handling your cat or cleaning their litter box and bedding.
Credit: AI generated image
Many people carry the thalassemia gene without knowing it because they may not have any symptoms. A simple carrier screening test before pregnancy can help couples understand risks and make informed decisions while planning parenthood.
Parenthood planning today is not only about financial preparation or healthy lifestyle changes, but also about understanding genetic health risks that can impact the child’s future. And one such condition that tends to go unnoticed is thalassemia carrier status.
Did you know? Many individuals discover they are carriers only after facing difficulties during pregnancy or after the birth of a child with thalassemia major.
Thalassemia is an inherited blood disorder that affects the production of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. People who are carriers usually live normal and healthy lives and may not experience major symptoms. Because of this, many remain unaware of their carrier status for years.
However, it becomes a matter of concern when both partners are carriers of the thalassemia gene. In such cases, there is a huge risk that the child may inherit thalassemia major, a severe condition that may require lifelong blood transfusions, regular hospital visits, medications, and continuous medical care.
These are some of the challenges faced by families: So, challenges are that the thalassemia carrier status is often detected very late. Mild tiredness or anemia may be ignored or mistaken for iron deficiency, and many will not seek help.
So, couples do not consider genetic testing before marriage or pregnancy because they feel healthy and have no family history of the disease. When a child is born with thalassemia major, families may face stress, anxiety, repeated hospital visits, financial burden, and long-term treatment responsibilities. The condition can also affect the child’s growth, immunity, and overall quality of life.
This is why screening is important for couples: Carrier screening is a simple blood test that helps identify whether a person carries the thalassemia gene. If one partner tests positive, the other partner is advised to get tested as well.
Early screening before pregnancy helps couples understand their risks and explore available options with proper guidance. Thalassemia carrier screening is a small step that can make a major difference in parenthood planning.
Increasing awareness and encouraging timely testing can help families make informed decisions and reduce the burden of severe thalassemia in future generations. So, it is imperative to go for timely screening as advised by the expert and improve the quality of life.
Credit: iStock
Mental health issues among doctors remain a serious but rarely discussed concern within the medical community, said Dr. Cyriac Abby Philips, popularly known on social media as the LiverDoc.
In an exclusive interaction with HealthandMe, the noted hepatologist highlighted the rising cases of burnout, depression, and suicide among healthcare professionals and the urgent need to address them.
He stated that doctors are among the major communities affected by mental health disorders, although the topic is often ignored within the profession.
“We have had very senior doctors die by suicide because of burnout,” he said, citing incidents involving highly successful doctors recently reported from parts of India, including Kerala.
Liver Doc stressed that addressing doctors’ mental health is as important as treating patients’ mental health.
“A doctor who has good mental health will be a much better ally for the patient when it comes to treatment,” he said.
He also urged the medical community and regulatory authorities to introduce more interventions and support systems to prevent burnout and mental health disorders among doctors.
According to him, the emotional burden of treating critically ill patients and witnessing deaths regularly can deeply affect healthcare professionals.
“It’s depressing to treat patients and see them die. It’s depressing to see another human die,” he said.
The expert noted that doctors should find ways to openly discuss and process emotional stress and mental health struggles.
Dr. Philips also addressed the issue in his recently released book, The Liver Doctor: Stories of Love, Loss and Regeneration.
He told HealthandMe that he has “very thoroughly and in very raw format addressed in the book” the mental health disorders affecting doctors, as it directly impacts patient care.
“Like every other doctor, I have also gone through that, and it's depressing to treat patients and see them die. I have this book to channelize that, and I feel less burdened when I do that, but other doctors also should find ways to do this. So this book also tells doctors to be more open about their mental health,” he said.
Doctors in teaching hospitals often endure long, unregulated shifts with little time for rest, especially during residency. Such exhausting work conditions not only increase the risk of medical errors but also significantly contribute to burnout, emotional exhaustion, and mental health problems among young doctors.
As per a recent nationwide survey on doctors’ mental health and morale, nine in ten doctors said they would not want their children to become physicians.
Also read: Global Mental Disorders Double In 33 Years, Affecting 1.2 Billion People: Study
The study, conducted by the Debabrata Mitalee Auro Foundation, surveyed 1,208 doctors across metropolitan cities and smaller towns over six months and found deep levels of burnout, fear of violence, and rising medico-legal anxiety among medical professionals.
Further, the Parliamentary Standing Committee on Health and Family Welfare also raised concerns over “excessive continuous duty hours” for junior and senior resident doctors in April.
In its latest report, the panel warned that fatigue-driven errors and burnout could compromise care.
The Panel recommended that the government introduce and strictly enforce a formal “Clinical Duty Hours Regulation” policy. This would mandate fixed rest periods and monitored duty rosters, with oversight mechanisms to prevent violations.
Credit: iStock
India’s cell and gene therapy ecosystem is beginning to attract a different kind of attention that is driven not just by healthcare demand, but by proprietary science and platform-led innovation.
For investors, however, the larger story may not be the funding round itself. It may be the problem the company is trying to solve.
CAR-T therapies have transformed outcomes for several difficult-to-treat blood cancers globally. But despite strong initial responses, relapse remains one of the field’s biggest limitations. One reason is antigen escape, which means cancer cells can change the markers that therapies use to identify them, making them harder to detect over time.
In an analysis of 4,129 CAR-T treated patients, relapse remained a substantial issue after single-target therapy, with 42.1% of relapses associated with loss of the CD19 target itself. The finding points to a larger issue: precision may not be enough if therapies lose visibility over time.
The response increasingly appears to be a move toward multi-target and more durable platforms. A bispecific CAR-T platform designed to recognize more than one tumor marker, to reduce relapse is crucial.
The science itself is becoming increasingly platform-oriented. Beyond broader targeting, recent work explored why immune cells themselves lose effectiveness over time and identified pathways associated with stronger persistence and memory. While still early, the broader implication is that future therapies may need to be designed not only to attack disease, but also to remain active longer.
For India, that creates a larger opportunity. Historically, advanced therapies such as CAR-T have remained expensive and heavily dependent on technologies developed elsewhere. The aim is to significantly reduce treatment costs while building indigenous capabilities across design and manufacturing.
The shift matters because biotech investing is increasingly moving beyond services and generics toward intellectual property and platform science. The transition from bedside observations to translational platforms may be where the next phase of healthcare innovation and investment gets built.
© 2024 Bennett, Coleman & Company Limited